2008
DOI: 10.1039/b710578a
|View full text |Cite
|
Sign up to set email alerts
|

Mixed ligand ruthenium(ii) complexes of bis(pyrid-2-yl)-/bis(benzimidazol-2-yl)-dithioether and diimines: Study of non-covalent DNA binding and cytotoxicity

Abstract: A series of mixed ligand ruthenium(II) complexes [Ru(pdto)(diimine)](ClO4)2/(PF6)2 1-3 and [Ru(bbdo)(diimine)](ClO4), 4-6, where pdto is 1,8-bis(pyrid-2-yl)-3,6-dithiooctane, bbdo is 1,8-bis(benzimidazol-2-yl)-3,6-dithiooctane and diimine is 1,10-phenanthroline (phen), dipyrido-[3,2-d:2',3'-f]-quinoxaline (dpq) and dipyrido[3,2-a:2',3'-c]phenazine (dppz), have been isolated and characterised by analytical and spectral methods. The complexes [Ru(pdto)(phen)](PF6)2 la, [Ru(pdto)(dpq)(Cl](PF6) 2a, [Ru(bbdo)(phen)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
58
0
1

Year Published

2008
2008
2019
2019

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 129 publications
(64 citation statements)
references
References 98 publications
5
58
0
1
Order By: Relevance
“…This is probably not the case of the nitrosyl complexes in this study since they are hexacoordinated and very stable in incubation solution. Therefore, one possible mechanism to explain the activity of our nitrosyl complexes could be similar to those reported earlier suggesting the intercalation of ruthenium compound containing bidentate ligands with DNA [54][55][56]. However, we do not exclude the possibility of a parallel mechanism involving the dissociation of the NO from the metal center in the nitrosyl complexes, in which this molecule could play a synergistic role inhibiting metalloproteinase enzymes, in particular MMP-2 and MMP-9, as suggested for the complexes [3-pyhaH][trans-RuCl 4 (dmso-S)(3-pyha)] and [4-pyhaH][trans-RuCl 4 (dmso-S)(4-pyha)](X-pyha = X-pyridinehydroxamic acid) in which the NO is generated from the hydroxamic acids, under physiological conditions [57].…”
Section: Antitumoral Activitysupporting
confidence: 80%
“…This is probably not the case of the nitrosyl complexes in this study since they are hexacoordinated and very stable in incubation solution. Therefore, one possible mechanism to explain the activity of our nitrosyl complexes could be similar to those reported earlier suggesting the intercalation of ruthenium compound containing bidentate ligands with DNA [54][55][56]. However, we do not exclude the possibility of a parallel mechanism involving the dissociation of the NO from the metal center in the nitrosyl complexes, in which this molecule could play a synergistic role inhibiting metalloproteinase enzymes, in particular MMP-2 and MMP-9, as suggested for the complexes [3-pyhaH][trans-RuCl 4 (dmso-S)(3-pyha)] and [4-pyhaH][trans-RuCl 4 (dmso-S)(4-pyha)](X-pyha = X-pyridinehydroxamic acid) in which the NO is generated from the hydroxamic acids, under physiological conditions [57].…”
Section: Antitumoral Activitysupporting
confidence: 80%
“…Research groups of Sadler, Dyson, Keppler and Reedijk have synthesized a remarkably large number of Ru(II)/Ru(III) organometallic complexes that are being tested for anticancer activity [1][2][3][4][5][6][7][8][9][10]. Ruthenium complexes are quite cytotoxic but do not affect normal cells significantly [11,12].…”
Section: Introductionmentioning
confidence: 99%
“…4 at a constant concentration of compound, 25 lg/ml). Since pyridine moieties are present in the compounds, we expect these compounds to insert partially in the DNA base pairs, leading to a decrease in transition energy, accounting for hypochromism and bathochromism [46][47][48][49]. However, upon incremental addition of DNA to L-L and 1, the bands at 209 and 213 nm underwent hyperchromism and shifted slightly to 2-3 nm (blue shift) (Fig.…”
Section: Absorption Spectral Datamentioning
confidence: 99%